当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Laura Morton*
We report the case of a heavy cannabis and tobacco user tracked over a fifteen-week treatment episode comprising tobacco and cannabis cessation interventions, with successive follow-ups at three, six and nine months.
Upon treatment exit, the client was abstinent from both cannabis and tobacco, sustained at three-month followup. At six months, the client had returned to smoking tobacco but maintained abstinence from cannabis. At final follow-up the client reported several lapses of cannabis use alongside continued tobacco smoking.
The case suggests that, for some clients at least, over the initial withdrawal period abstinence from one substance does not undermine abstinence from another. It also suggests that clients accessing community drug treatment may benefit from concurrent smoking cessation interventions, and that addressing stress may be key to sustaining positive treatment outcomes.